Full-Time

Manager – Technical Accounting and Tax

Posted on 4/18/2024

BlueRock Therapeutics

BlueRock Therapeutics

201-500 employees

Clinical stage cell therapy company

Biotechnology

Mid, Senior

Toronto, ON, Canada

Requirements
  • Bachelor's degree in Accounting
  • 5+ years of accounting experience
  • CPA required
  • Experience with the review of the application of IFRS rules to complex technical accounting issues
  • Strong Knowledge of IFRS
  • Strong analytical, problem-solving skills and collaborative skills
  • Excellent verbal and written communication skills
  • Ability to multi-task on competing and deadline driven priorities
  • Ability to work effectively with all levels in the organization
  • Strong organizational skills and process orientated
  • Biotech experience a preferred
Responsibilities
  • Take ownership of and maintain a strong and effective Internal Control environment
  • Perform technical accounting consultations and resolution of complex accounting transactions
  • Manage General Ledger accounting and the lead aspects of monthly/quarterly/year-end close, including preparing/reviewing journal entries and account reconciliations
  • Oversee the analysis of financial due diligence processes to suggest treatment of key collaboration agreements
  • Implement new accounting standards including issuance and updating of corporate accounting policies and procedures
  • Assist in monitoring and maintenance of ERP systems, including managing accounting close processes and deadlines
  • Manage the timely accurate preparation and submission of all provisional Tax related filings
  • Participate in preparation of internal and external financial statements
  • Remain current with the latest developments in accounting and financial reporting
  • Contribute to system implementations and other special projects

BlueRock Therapeutics is a clinical stage cell therapy company focused on harnessing the power of cell therapy to replace damaged or lost cells in order to create medicines for neurology, cardiology, and immunology indications. Their cell+gene platform utilizes cell differentiation technology to produce authentic cell therapies, with the potential to restore or regenerate lost function.

Company Stage

M&A

Total Funding

$807M

Headquarters

Cambridge, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

1%

2 year growth

54%